Symeres appoints Henning Steinhagen as CEO to drive next phase of global growth
Steinhagen brings more than 25 years of leadership experience spanning pharma, biotech and the CRO/CDMO sector
Steinhagen brings more than 25 years of leadership experience spanning pharma, biotech and the CRO/CDMO sector
Dr Reddy has made remarkable contributions towards advancing cancer care through clinical excellence, pioneering research, academic mentorship, and compassionate healing
The clinical study in France evaluated the safety and feasibility of Robocath’s robotic-assisted coronary intervention platform across complex cardiac cases.
Mumbai event on June 24–25 will spotlight real-world impact of pharmacovigilance beyond AI adoption
Expands manufacturing push & locks in major growth deals
Initiative launched with Tata 1mg to benefit 70,000 people across 70 remote villages in Kalahandi region
NEJM study shows strong protection across strains
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
These check-ups will be conducted through ESIC’s extensive network of hospitals, with a focus on early diagnosis, preventive healthcare, and continuous health monitoring
Successful inspection outcome strengthens company’s regulatory compliance and manufacturing standards in China
Subscribe To Our Newsletter & Stay Updated